Bipolar Clinic and Research Program, Department of Psychiatry, Massachusetts General Hospital, Boston, MA.
Bipolar Disord. 2015 Mar;17(2):212-23. doi: 10.1111/bdi.12243. Epub 2014 Aug 16.
Individuals with bipolar disorder have high rates of other medical comorbidity, which is associated with higher mortality rates and worse course of illness. The present study examined common predictors of medical comorbidity.
The Clinical and Health Outcomes Initiative in Comparative Effectiveness for Bipolar Disorder study (Bipolar CHOICE) enrolled 482 participants with bipolar I or bipolar II disorder in a six-month, randomized comparative effectiveness trial. Baseline assessments included current and lifetime DSM-IV-TR diagnoses, demographic information, psychiatric and medical history, severity of psychiatric symptoms, level of functioning, and a fasting blood draw. Medical comorbidities were categorized into two groups: cardiometabolic (e.g., diabetes, hyperlipidemia, and metabolic syndrome) and non-cardiovascular (e.g., seizures, asthma, and cancer). Additionally, we looked at comorbid substance use (e.g., smoking and drug dependence).
We found that 96.3% of participants had at least one other medical comorbidity. Older age predicted a greater likelihood of having a cardiometabolic condition. Early age of onset of bipolar symptoms was associated with a lower chance of having a cardiometabolic condition, but a greater chance of having other types of medical comorbidity. Additional predictors of other medical comorbidities in bipolar disorder included more time spent depressed, less time spent manic/hypomanic, and longer duration of illness. Medications associated with weight gain were associated with low high-density lipoprotein and abnormal triglycerides.
There appears to be a substantial medical burden associated with bipolar disorder, highlighting the need for collaborative care among psychiatric and general medical providers to address both psychiatric and other medical needs concomitantly in this group of patients.
双相情感障碍患者存在较高的其他合并症发生率,这与更高的死亡率和更差的疾病进程有关。本研究旨在探讨常见的合并症预测因素。
双相情感CHOICE 临床和健康结果比较有效性研究(Bipolar CHOICE)纳入了 482 名双相 I 型或双相 II 型障碍患者,进行了为期 6 个月的随机比较有效性试验。基线评估包括当前和终生 DSM-IV-TR 诊断、人口统计学信息、精神病史和医疗史、精神症状严重程度、功能水平以及空腹采血。将合并症分为两类:心血管代谢(如糖尿病、血脂异常和代谢综合征)和非心血管(如癫痫发作、哮喘和癌症)。此外,我们还研究了合并的物质使用(如吸烟和药物依赖)。
我们发现,96.3%的参与者至少有一种其他合并症。年龄较大预示着更有可能患有心血管代谢疾病。双相情感障碍症状的发病年龄较早与患心血管代谢疾病的几率较低有关,但与其他类型的合并症的几率较高有关。双相情感障碍其他合并症的其他预测因素包括抑郁时间更长、躁狂/轻躁狂时间更短、疾病持续时间更长。与体重增加相关的药物与低高密度脂蛋白和异常甘油三酯有关。
双相情感障碍患者似乎存在相当大的医疗负担,这凸显了精神科和普通医疗提供者之间需要协作,共同满足这组患者的精神和其他医疗需求。